用高表达EGFR细胞膜色谱-HPLC/MS联用快速筛选独活中抗EGFR活性成分

报道了用高表达表皮生长因子受体细胞膜色谱与高效液相色谱/质谱在线联用方法(EGFR/CMC-online-HPLC/MS)快速筛选发现中药独活中的活性成分.实验中,采用高表达EGFR的细胞膜制备色谱固定相,建立EGFR/细胞膜色谱(EGFR/CMC)模型,利用柱切换和固相萃取技术,将EGFR/CMC模型与高效液相色谱/质谱(HPLC/MS)在线联用,构成一种新的可同时"识别-鉴定"目标成分的二维色谱系统,并应用于快速筛选独活中具有抗EGFR活性的目标成分.结果发现独活中的蛇床子素具有与对照药物达沙替尼类似的色谱保留特性,能够作用于EGFR;同时MTT及Elisa分析实验证实蛇床子素对HEK293EGFR细胞增殖及EGFR表达均有抑制作用.本文建立的EGFR/CMC-online-HPLC/MS二维色谱方法,可以选择性地从中药复杂体系中快速"识别-鉴定"目标组分,且筛选结果与特定生物效应显著相关.     

酪氨酸激酶抑制剂的三维定量构效关系研究

利用柔性原子受体模型(FLARM)方法对一系列的异黄酮和喹诺酮衍生物表皮生长因子受体酪氨酸激酶抑制剂进行了三维定量构效关系研究，得到了合理的构效关系模型.FLARM方法的计算结果还给出了虚拟的受体模型，该模型说明了抑制剂与受体之间可能的相互作用.由该虚拟受体模型得到的受体-配体相互作用与Novartis药效团模型比较类似.     

液相色谱法测定抗体与对硫磷、异丙威及其竞争原的吸附常数

为建立一种测定抗体与小分子化合物吸附性能的色谱分析方法,本研究设计合成了5种对硫磷半抗原和2种异丙威半抗原,将半抗原P1和A1与同一载体蛋白偶联制备"多簇"免疫抗原,免疫动物获得相应的多克隆抗体;采用高效液相色谱结合固相吸附的方法,测定了抗体与对硫磷、异丙威及其竞争原的吸附性能,并通过吸附动力学模型拟合抗体与化合物的吸附行为,获得相应的吸附常数。结果表明抗体与小分子化合物的吸附动力学符合Freundilich模型,抗体与不同化合物的吸附常数为:对硫磷>P1>P4>P3>P2>P5,大小顺序与ELISA亲和常数的测定结果相符,与ELISA灵敏度测定结果有很好的相关性。     

基于碳纳米管载体的丙烯酰胺免疫亲和吸附剂的研究

自从在油炸及烧烤的淀粉类食品中检测到具有潜在致癌风险的丙烯酰胺副产物后,发展简单实用的丙烯酰胺检测方法的研究备受重视~([1]).以N-羟基琥珀酰亚胺丙烯酸酯(NAS)为半抗原,成功制备了对丙烯酰胺具有特异性识别和结合作用的多克隆抗体,建立了能够对淀粉类食品中丙烯酰胺进行快速检测的生物素-亲和素酶联免疫分析方法~([2]).     

有机磷农药半抗原设计及多特异性抗体识别机制研究

基于抗原-抗体特异性识别、可同时检测多个对象的多残留免疫分析技术因具有简便、低成本、高通量等特点成为研究热点。作者前期以二乙氧基硫代磷酸酯类有机磷农药为对象,通过设计一系列半抗原,制备了有机磷农药多特异性抗体,并借助分子模拟、光谱分析、基因工程技术等手段从构效关系、弱相互作用及空间识别模型等方面研究了抗体识别机制,建立"半抗原-赖氨酸偶联物"模型用于研究半抗原与载体蛋白偶联后的空间构象及静电势能变化;提出"抗体与有机磷农药的识别与其最低空轨道能量和油水分配系数呈线性相关"的理论基础.本文对课题组近年来在该领域取得的研究成果进行了归纳总结,期望对指导小分子化合物半抗原的设计、多残留免疫分析方法的建立等提供借鉴.     

酶联免疫法检测新型除草剂双甲胺草磷

以甲醇与三氯硫磷为原料,人工合成了半抗原结构类似物,与琥珀酸酣反应引入羧基,利用活性酯法使之与载体蛋白偶联,制得完全抗原,免疫动物获得多克隆抗体,建立了新型除草剂双甲胺草磷(H-9201)的间接竞争ELISA检测方法,并进行了水体中除草剂H-9201残留的实际样品检测.结果表明:所获得的多克隆抗体可以特异性的识别目标化...     

基于毛细管电泳酶微反应器的吉非替尼对表皮生长因子受体抑制率的测定

采用共价键法将表皮生长因子受体固定在毛细管内壁,制备了一种毛细管电泳酶微反应器。结合毛细管电泳高效分离技术,以三磷酸腺苷为底物,吉非替尼为抑制剂,利用表皮生长因子受体酶微反应器在线测定了吉非替尼对皮生长因子受体的抑制性能。结果显示,吉非替尼可竞争性的抑制三磷酸腺苷与表皮生长因子受体的结合,从而影响三磷酸腺苷与表皮生长因子受体的结合量以及产物二磷酸腺苷的生成量。根据不同浓度吉非替尼下三磷酸腺苷峰面积的变化计算了吉非替尼对表皮生长因子受体的抑制率。同时绘制了抑制曲线,得到IC50值为32.44±0.82μmol/L。实验表明该酶微反应器可实际用于酪氨酸激酶抑制剂的抑制率的快速测定。     

醚型菊酯类农药通用抗原的合成及鉴定

以2-(4-乙氧基苯基)-2-甲基丙醇和氯乙酸钠为原料,合成了醚型菊酯类农药通用半抗原Hapten I,经1 H-NMR及13C-NMR鉴定后,分别与牛血清蛋白(BSA)和卵清白蛋白(OVA)偶联,制得免疫原和包被原,经紫外光谱分析法计算得其偶联比分别为14∶1和35∶1,说明人工抗原合成成功.免疫Balb/c小鼠制备多克隆抗体,效价达1.28×105,用半抗原经间接竞争ELISA检测人工抗原的免疫原性,IC50和IC10值分别为0.2653和0.0012 mg/L,证明人工抗原具有较好的免疫原性.交叉反应表明此多克隆抗体具有良好的特异性.     

表皮生长因子受体的ATP竞争性抑制剂

综述了表皮生长因子受体酪氨酸激酶的ATP竞争性抑制剂的研究进展,介绍了抑制剂结合受体蛋白的方式及其作用机理,重点介绍了可逆抑制剂和不可逆抑制剂的作用机理及其构效关系.     

去甲氯胺酮半抗原及其全抗原的合成与鉴定

在低温条件下,去甲氯胺酮与琥珀醛酸反应,合成了半抗原羧基-去甲氯胺酮,电喷雾质谱鉴定结果表明,目标半抗原合成成功;通过碳二亚胺法将半抗原与载体蛋白偶联制备人工抗原,红外光谱法鉴定结果表明,人工抗原合成成功,基质辅助激光解析电离飞行时间质谱鉴定表明去甲氯胺酮半抗原与牛血清白蛋白的偶联比为11:1。经动物免疫,获得高效价特异性多克隆抗体,抗血清效价可达5.12×104。     

禽流感病毒流式微球量子点探针免疫诊断新方法

采用微波法水相中合成羧基化的绿色量子点,通过羧基与禽流感单克隆抗体氨基的共价结合,制备了检测禽流感病毒的探针,并结合流式微球技术,建立了量子点生物探针流式微球免疫检测禽流感病毒的新方法.以聚苯乙烯微球为蛋白质载体,将多克隆抗体包被到荧光微球上,依次加入待测抗原和量子点生物探针,形成双抗体夹心复合物,用流式细胞仪进行检测.实验结果表明,多抗和单抗的最佳质量浓度分别为92和4 mg/L,检测禽流感病毒比双抗体夹心ELISA灵敏16倍,比FITC标记单抗检测方法灵敏4倍.对阳性尿囊液的检测与ELISA呈现良好的相关性,不与鸡传染性支气管炎病毒、鸡马力克氏病毒、新城疫病毒等发生交叉反应.     

Antibody modified Bovine Serum Albumin microspheres for targeted delivery of anticancer agent Gemcitabine

Inhibition of the EGFR signaling pathway is one of the attractive therapeutic targets for pancreatic cancer as recent studies demonstrated that EGFR is over‐expressed in pancreatic cancer. In this article we have demonstrated the design of targeted drug delivery system containing Bovine Serum Albumin (BSA) microspheres as delivery vehicle, gemcitabine as anticancer drug and anti‐EGFR (epidermal growth factor receptor) monoclonal antibody as targeting agent. The conjugated BSA microspheres were characterized by several physico‐chemical techniques such as scanning electron microscope, optical microscopy, fluorescent microscopy etc. Administration of these BSA microspheres containing gemcitabine and anti‐EGFR (BSA‐Gem‐EGFR) shows significant inhibition of pancreatic cancer cells (AsPC1) compared to the cells treated with only BSA microspheres, BSA with gemcitabine (BSA‐Gem), and free gemcitabine. This strategy could be used as a generalized approach for the treatment of pancreatic cancer along with other cancers which overexpress EGFR on cell surface. Copyright © 2012 John Wiley & Sons, Ltd.     

Block copolymer micelles conjugated with anti‐EGFR antibody for targeted delivery of anticancer drug

Antiepidermal growth factor receptor antibody (anti‐EGFR antibody) was conjugated with the block copolymer micelle based on poly(ethylene glycol) (PEG) and poly(ε‐caprolactone) (PCL) for active targeting to EGFR overexpressing cancer cells. Doxorubicin (DOX) was encapsulated in the core of the block copolymer (MePEG‐b‐PCL) micelle (DOX‐micelle). The mean diameters of the DOX‐micelle and the anti‐EGFR‐PEG‐b‐PCL copolymer micelles loaded with DOX (DOX‐anti‐EGFR‐micelle) were about 25 and 31 nm, respectively. The RKO human colorectal cancer cells expressing moderate degree of EGFR were incubated with free DOX, DOX‐micelle, or DOX‐anti‐EGFR‐micelle to study the distribution of DOX in the cells. When cells were incubated with free DOX, moderate degree of DOX fluorescence was observed in the nuclei. In the cells treated with DOX‐micelle, the DOX fluorescence intensity in the cytoplasm was much greater than that in the nuclei. On the other hand, the nuclei of the cells treated with DOX‐anti‐EGFR‐micelle exhibited DOX fluorescence intensity similar to that in the cytoplasm. The cytotoxicity of DOX‐anti‐EGFR‐micelle to induce apoptosis in RKO cells was significantly greater than that of free DOX or DOX‐micelle. These results demonstrated that the presence of anti‐EGFR antibody on the DOX‐micelle surface (DOX‐anti‐EGFR‐micelle) increased the internalization of the DOX‐micelle and nuclear accumulation of DOX, and enhanced the DOX‐induced cell death. © 2008 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 46: 7321–7331, 2008     

曼氏血吸虫谷胱甘肽S-转移酶Sm26/2的抗原肽研究

在计算机辅助下,应用Goldkey和PC-Gene程序,根据新报道的曼氏血吸虫谷胱甘肽S-转移酶Sm26/2的氨基酸序列,进行亲水性、柔韧性、可接近性、电荷分布和二级结构分析,预测出6个抗原肽,并用固相法进行了合成.经Dot-ELISA法测定,其中的2个对抗日本血吸虫免疫球蛋白多克隆抗体(抗-Sj-IgG-PcAb)显示出较好的抗原性,1个对抗血吸虫表膜单克隆抗体(A6McAb)显示出较好的抗原性,可作为抗血吸虫病合成多肽疫苗的候选肽段.     

Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells

Lysophosphatidic acid (LPA) is a bioactive phospholipids and involves in various cellular events, including tumor cell migration. In the present study, we investigated LPA receptor and its transactivation to EGFR for cyclooxygenase-2 (COX-2) expression and cell migration in CAOV-3 ovarian cancer cells. LPA induced COX-2 expression in a dose-dependent manner, and pretreatment of the cells with pharmacological inhibitors of Gi (pertussis toxin), Src (PP2), EGF receptor (EGFR) (AG1478), ERK (PD98059) significantly inhibited LPA-induced COX-2 expression. Consistent to these results, transfection of the cells with selective Src siRNA attenuated COX-2 expression by LPA. LPA stimulated CAOV-3 cell migration that was abrogated by pharmacological inhibitors and antibody of EP2. Higher expression of LPA2 mRNA was observed in CAOV-3 cells, and transfection of the cells with a selective LPA2 siRNA significantly inhibited LPA-induced activation of EGFR and ERK, as well as COX-2 expression. Importantly, LPA2 siRNA also blocked LPA-induced ovarian cancer cell migration. Collectively, our results clearly show the significance of LPA2 and Gi/Src pathway for LPA-induced COX-2 expression and cell migration that could be a promising drug target for ovarian cancer cell metastasis.     

Anti-epidermal growth factor receptor (anti-EGFR) antibody conjugated fluorescent nanoparticles probe for breast cancer imaging

Fluorescent nanoparticles (FNs) with unique optical properties may be useful as biosensors in living cancer cell imaging and cancer targeting. In this study, anti-EGFR antibody conjugated fluorescent nanoparticles (FNs) (anti-EGFR antibody conjugated FNs) probe was used to detect breast cancer cells. FNs with excellent character such as non-toxicity and photostability were first synthesized with a simple, cost-effective and environmentally friendly modified Stőber synthesis method, and then successfully modified with anti-EGFR antibody. This kind of fluorescence probe based on the anti-EGFR antibody conjugated FNs has been used to detect breast cancer cells with fluorescence microscopy imaging technology. The experimental results demonstrate that the anti-EGFR antibody conjugated FNs can effectively recognize breast cancer cells and exhibited good sensitivity and exceptional photostability, which would provide a novel way for the diagnosis and curative effect observation of breast cancer cells and offer a new method in detecting EGFR.     

Facile Synthesis of Novel Perfluorocarbon‐Modulated 4‐Anilinoquinazoline Analogues

4‐Anilinoquinazoline analogues stand out among many kinds of small molecules that inhibit the tyrosine kinase activities of epidermal growth factor receptor (EGFR ), thus serving as significant molecular targets for anticancer drug design. Herein, a series of novel perfluorocarbon (PFC ) modulated 4‐anilinoquinazolines were designed and prepared straightforwardly by nucleophilic substitution reaction of various anilinoquinazolines and PFC ‐derived methanesulfonate. In the presence of base, the reaction proceeded smoothly to afford a wide range of 4‐anilinoquinazolines with different substituents on aniline moiety in good to high yields. Furthermore, the PFC ‐modified analogues of gefitinib and erlotinib were also obtained in 93% and 90% respectively, which may have potential for developing new inhibitors of the epidermal growth factor receptor (EGFR ) tyrosine kinase and fluorinated contrast agents (CA ) for ¹⁹F MRI .     

Synthesis and Use of a Phosphonate Amidine to Generate an Anti‐Phosphoarginine‐Specific Antibody

Protein arginine phosphorylation is a post‐translational modification (PTM) that is important for bacterial growth and virulence. Despite its biological relevance, the intrinsic acid lability of phosphoarginine (pArg) has impaired studies of this novel PTM. Herein, we report for the first time the development of phosphonate amidines and sulfonate amidines as isosteres of pArg and then use these mimics as haptens to develop the first high‐affinity sequence independent anti‐pArg specific antibody. Employing this anti‐pArg antibody, we further showed that arginine phosphorylation is induced in Bacillus subtilis during oxidative stress. Overall, we expect this antibody to see widespread use in analyzing the biological significance of arginine phosphorylation. Additionally, the chemistry reported here will facilitate the generation of pArg mimetics as highly potent inhibitors of the enzymes that catalyze arginine phosphorylation/dephosphorylation.     

A Sensitive Electrochemical Biosensor for Detection of Histone Deacetylase Activity Using an Acetylated Peptide

A sensitive electrochemical biosensor was developed for activity detection of histone deacetylase sirtuin2 (SIRT2) using an acetylated peptide substrate. This substrate could be recognized by anti‐acetylated peptide antibody, which could be detected using secondary antibody conjugated alkaline phosphatase which provided an amplified electrochemical signal. In the presence of SIRT2, the substrate was deacetylated, resulting in a decreased electrochemical signal that was correlated to the concentration of SIRT2. Under optimized conditions, the biosensor exhibited a wide linear range from 1 nM to 500 nM with a detection limit of 0.1 nM. The proposed biosensor was also used for detection of SIRT2 inhibitor.